65 related articles for article (PubMed ID: 27862653)
1. Reply: Adenosine Producing Mesenchymal Stromal Cells.
Kerkelä E
Stem Cells; 2017 Jun; 35(6):1649-1650. PubMed ID: 27862653
[TBL] [Abstract][Full Text] [Related]
2. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.
Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J
Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405
[TBL] [Abstract][Full Text] [Related]
6. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses.
Chen X; Shao H; Zhi Y; Xiao Q; Su C; Dong L; Liu X; Li X; Zhang X
Stem Cells Dev; 2016 Feb; 25(4):337-46. PubMed ID: 26650818
[TBL] [Abstract][Full Text] [Related]
7. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Producing Mesenchymal Stem Cells.
Schuler PJ; Brandau S
Stem Cells; 2017 Jun; 35(6):1647-1648. PubMed ID: 27859896
[TBL] [Abstract][Full Text] [Related]
9. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Deaglio S; Dwyer KM; Gao W; Friedman D; Usheva A; Erat A; Chen JF; Enjyoji K; Linden J; Oukka M; Kuchroo VK; Strom TB; Robson SC
J Exp Med; 2007 Jun; 204(6):1257-65. PubMed ID: 17502665
[TBL] [Abstract][Full Text] [Related]
10. Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression.
de Oliveira Bravo M; Carvalho JL; Saldanha-Araujo F
Purinergic Signal; 2016 Dec; 12(4):595-609. PubMed ID: 27557887
[TBL] [Abstract][Full Text] [Related]
11. Studies of the extracellular ATP-adenosine pathway in human urinary tract epithelial cells.
Mohlin C; Säve S; Nilsson M; Persson K
Pharmacology; 2009; 84(4):196-202. PubMed ID: 19729987
[TBL] [Abstract][Full Text] [Related]
12. Immortalization of Mesenchymal Stromal Cells by TERT Affects Adenosine Metabolism and Impairs their Immunosuppressive Capacity.
Beckenkamp LR; da Fontoura DMS; Korb VG; de Campos RP; Onzi GR; Iser IC; Bertoni APS; Sévigny J; Lenz G; Wink MR
Stem Cell Rev Rep; 2020 Aug; 16(4):776-791. PubMed ID: 32556945
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
14. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice.
Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T
Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240
[TBL] [Abstract][Full Text] [Related]
15. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes
Monguió-Tortajada M; Roura S; Gálvez-Montón C; Franquesa M; Bayes-Genis A; Borràs FE
Front Immunol; 2017; 8():1577. PubMed ID: 29209319
[TBL] [Abstract][Full Text] [Related]
17. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
[TBL] [Abstract][Full Text] [Related]
19. Extracellular ATP inhibits IL-1-induced MMP-1 expression through the action of CD39/nucleotidase triphosphate dephosphorylase-1 on human gingival fibroblasts.
Nemoto E; Gotoh K; Tsuchiya M; Sakisaka Y; Shimauchi H
Int Immunopharmacol; 2013 Nov; 17(3):513-8. PubMed ID: 23941770
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas.
Bray LJ; Heazlewood CF; Munster DJ; Hutmacher DW; Atkinson K; Harkin DG
Cytotherapy; 2014 Jan; 16(1):64-73. PubMed ID: 24094499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
